House Bill
|
1074
|
An Act relative to cancer patient access to biomarker testing to provide appropriate therapy
|
Oppose
|
$0.00
|
n/a
|
Senate Bill
|
647
|
An Act relative to preserving preventive services without cost sharing
|
Support
|
$0.00
|
n/a
|
Executive
|
Division of Capital Asset Management and Maintenance (DCAMM) (Executive Office for Administration and Finance)
|
Discussions with Division of Insurance on Final Bulletins on Chapters 127 and 177 of the Acts of 2022
|
Neutral
|
$0.00
|
n/a
|
House Bill
|
1068
|
An Act to further define medical necessity determinations
|
Oppose
|
$0.00
|
n/a
|
Senate Bill
|
645
|
An Act relative to out-of-network billing
|
Support
|
$0.00
|
n/a
|
Executive
|
Division of Insurance (Executive Office of Health and Human Services)
|
Discussions with Division of Insurance on Dental Ballot Question Implementation
|
Neutral
|
$0.00
|
n/a
|
House Bill
|
1201
|
An Act to promote transparency in prescription drug prices
|
Support
|
$0.00
|
n/a
|
Senate Bill
|
732
|
An Act relative to promoting comprehensive transparency in the pharmaceutical industry
|
Oppose
|
$0.00
|
n/a
|
Executive
|
MassHealth
|
Discussions with MassHealth regarding Senior Care Options - SCO and One Care Procurement
|
Neutral
|
$0.00
|
n/a
|
House Bill
|
1205
|
An Act relative to prescription drug price transparency
|
Oppose
|
$0.00
|
n/a
|
Senate Bill
|
736
|
An Act relative to the closing of hospital essential services
|
Support
|
$0.00
|
n/a
|
Executive
|
MassHealth
|
Discussions with MassHealth regarding Redeterminations
|
Neutral
|
$0.00
|
n/a
|
House Bill
|
1147
|
An Act ensuring access to specialty medications
|
Oppose
|
$0.00
|
n/a
|
Senate Bill
|
677
|
An Act relative to prescription-drug utilization review
|
Oppose
|
$0.00
|
n/a
|
Executive
|
Division of Insurance (Executive Office of Health and Human Services)
|
Discussions with Division of Insurance on Step Therapy
|
Neutral
|
$0.00
|
n/a
|
House Bill
|
986
|
An Act relative to telehealth and digital equity for patients
|
Oppose
|
$0.00
|
n/a
|
Senate Bill
|
3
|
An Act making appropriations for the fiscal year 2024 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements
|
Neutral
|
$0.00
|
n/a
|
Executive
|
Division of Insurance (Executive Office of Health and Human Services)
|
Discussions with Division of Insurance on on Implementation of Amendments to Small Group Regulations
|
Oppose
|
$0.00
|
N/A
|
Executive
|
Health Connector
|
Discussion with the Massachusetts Health Connector on Seal on MassHealth redeterminations
|
Neutral
|
$0.00
|
n/a
|
House Bill
|
1185
|
An Act strengthening market oversight of the Commonwealth's Health Care System
|
Support
|
$0.00
|
n/a
|
Senate Bill
|
704
|
An Act prohibiting discrimination against 340b drug discount program participants
|
Oppose
|
$0.00
|
n/a
|
Executive
|
Massachusetts Health Policy Commission (HPC)
|
Discussions with Health Policy Commission on Administrative Simplification
|
Neutral
|
$0.00
|
n/a
|
House Bill
|
1108
|
An Act relative to community behavioral health centers
|
Oppose
|
$0.00
|
n/a
|
Senate Bill
|
655
|
An Act relative to telehealth and digital equity for patients
|
Oppose
|
$0.00
|
n/a
|
Executive
|
Division of Insurance (Executive Office of Health and Human Services)
|
Discussions with Division of Insurance on COVID-19 Flexibilities and the end of the Public Health Emergency
|
Neutral
|
$0.00
|
n/a
|
House Bill
|
997
|
An Act to protect health care consumers from surprise billing
|
Support
|
$0.00
|
n/a
|
Senate Bill
|
630
|
An Act ensuring access to specialty medications
|
Oppose
|
$0.00
|
n/a
|
Executive
|
Division of Insurance (Executive Office of Health and Human Services)
|
Discussions with Division of Insurance on Emergency Services Programs
|
Neutral
|
$0.00
|
n/a
|
House Bill
|
979
|
An Act relative to transparency of hospital margins & ensuring hospital efficiency
|
Support
|
$0.00
|
n/a
|
House Bill
|
3584
|
An Act relative to requiring insurance providers cover a minimum of 30 days for in-patient substance abuse treatment
|
Oppose
|
$0.00
|
n/a
|
Senate Bill
|
789
|
An Act relative to hospital price transparency
|
Support
|
$0.00
|
n/a
|
Executive
|
Health Connector
|
Discussion with the Massachusetts Health Connector on Seal of Approval
|
Neutral
|
$0.00
|
n/a
|
House Bill
|
1176
|
An Act relative to promoting comprehensive transparency in the pharmaceutical industry
|
Oppose
|
$0.00
|
n/a
|
Senate Bill
|
689
|
An Act relative to patient access to biomarker testing to provide appropriate therapy
|
Oppose
|
$0.00
|
n/a
|
Executive
|
Massachusetts Health Policy Commission (HPC)
|
Discussions with Health Policy Commission on Affordability Agenda
|
Neutral
|
$0.00
|
n/a
|
House Bill
|
945
|
An Act to ensure prescription drug cost transparency and affordability
|
Oppose
|
$0.00
|
n/a
|
House Bill
|
1219
|
An Act enhancing the market review process
|
Support
|
$0.00
|
n/a
|
Senate Bill
|
761
|
An Act relative to hospital closures and health planning
|
Support
|
$0.00
|
n/a
|
Executive
|
Executive Office of Health and Human Services (EOHHS)
|
Discussions with Executive Office of Health and Human Services on Temporary Suspension of Prior Authorization for Post-Acute Care
|
Neutral
|
$0.00
|
n/a
|
House Bill
|
1
|
An Act making appropriations for the Fiscal Year 2024 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements
|
Neutral
|
$0.00
|
n/a
|
House Bill
|
1215
|
An Act relative to pharmacy benefit managers
|
Oppose
|
$0.00
|
n/a
|
Senate Bill
|
749
|
An Act relative to pharmaceutical access, costs and transparency
|
Support
|
$0.00
|
n/a
|
Executive
|
MassHealth
|
Discussions with Department of Public Health on Adult COVID-19 Vaccine Trust Fund
|
Neutral
|
$0.00
|
n/a
|
House Bill
|
959
|
An Act prohibiting discrimination against 340b drug discount program participants
|
Support
|
$0.00
|
n/a
|
House Bill
|
2163
|
An Act relative to postpartum depression screenings
|
Oppose
|
$0.00
|
n/a
|
Senate Bill
|
783
|
An Act to promote transparency and prevent price gouging of pharmaceutical drug prices
|
Support
|
$0.00
|
n/a
|
Executive
|
Executive Office of Health and Human Services (EOHHS)
|
Discussions with Executive Office of Health and Human Services on Closure of Compass Medical
|
Neutral
|
$0.00
|
n/a
|
House Bill
|
1144
|
An Act relative to specialty medications and patient safety
|
Oppose
|
$0.00
|
n/a
|
Senate Bill
|
665
|
An Act relative to specialty medications and patient safety
|
Oppose
|
$0.00
|
n/a
|
Executive
|
Division of Insurance (Executive Office of Health and Human Services)
|
Discussions with Division of Insurance on Step Therapy
|
Neutral
|
$0.00
|
n/a
|
House Bill
|
991
|
An Act relative to reimbursement for recovery peer specialists
|
Oppose
|
$0.00
|
n/a
|
Senate Bill
|
611
|
An Act relative to reimbursement for recovery peer specialists
|
Oppose
|
$0.00
|
n/a
|
Executive
|
Division of Insurance (Executive Office of Health and Human Services)
|
Discussions with Division of Insurance on Behavioral Health Wellness Exams
|
Neutral
|
$0.00
|
N/A
|
| | |
Total amount
|
$0.00
| |